Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Stability Study of Losartan Potassium and Hydrochlorothiazide tablets (CROSBI ID 713465)

Prilog sa skupa u časopisu | prošireni sažetak izlaganja sa skupa | međunarodna recenzija

Lusina, Maja ; Cindrić, Tanja ; Tomaić, Jadranka ; Ballian, Davorka Stability Study of Losartan Potassium and Hydrochlorothiazide tablets // Farmacevtski vestnik / Mrhar, Aleš (ur.). 2003. str. 491-492

Podaci o odgovornosti

Lusina, Maja ; Cindrić, Tanja ; Tomaić, Jadranka ; Ballian, Davorka

engleski

Stability Study of Losartan Potassium and Hydrochlorothiazide tablets

Stability study of losartan/hydrochlorothiazide tablets consisted of three steps: stress test (forced degradation study), preliminary testing (selection of packaging) and formal stability testing. The results of stress test suggested that losartan/hydrochlorothiazide tablets are sensitive to moisture. Additional preliminary testing was performed in order to select appropriate packaging for losartan/hydrochlorothiazide tablets. OPA/Al/PVC//Al blisters were found to provide adequate protection for the product. Based on the first 6 months of the formal stability study, a shelf life of 24 months was proposed. Losartan/hydrochlorothiazide tablets in OPA/Al/PVC//Al blisters are demonstrated to be chemically, physically and microbiologically stable.

losartan potassium ; hydrochlorothiazide ; stability testing ; packaging

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

491-492.

2003.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Farmacevtski vestnik

Mrhar, Aleš

Ljubljana:

0014-8229

Podaci o skupu

5th Central European Symposium on Pharmaceutical Technology and Biotechnology

poster

25.09.2003-27.09.2003

Ljubljana, Slovenija

Povezanost rada

Farmacija

Indeksiranost